The Rising Threat of Nitazenos in the Opioid Epidemic
Fentanyl has been the main protagonist of the opioid epidemic that has plagued the United States for decades, and whose consequences are now being globally felt. However, alongside fentanyl, other drugs are increasingly taking center stage during this crisis, bringing along their own set of challenges. Among these emerging threats is a category of opioids called nitazenos , which researchers are warning could be even more potent than fentanyl and more difficult to detect.
A “New” Risk: The Emergence of Nitazenos
A group of American researchers has highlighted the significant risks posed by nitazenos within the broader context of the opioid crisis. These compounds, developed in the 1950s , were never approved for medical use. Despite their long history, nitazenos are now resurging as a lethal component in the illicit drug market. “For patients, especially those with opioid use disorder or those exposed to illegal substances, nitazenos pose a serious, often hidden threat,” stated Shravani Durbhakula, a co-author of the study, in a press release. “Since these drugs do not appear in routine toxicology exams , healthcare providers could overlook a critical piece in diagnosis during overdose treatment,” she added. As a result, patients may require higher or repeated doses of naloxone, the medication typically used to reverse opioid overdoses, to counteract the effects of these potent substances.
The Alarming Statistics
According to the team’s research, data from the Toxicological Monitoring System in Tennessee indicates that between 2019 and 2023, nitazenos were detected in 92 deaths due to overdose. Alarmingly, these substances were usually found in combination with other drugs, typically fentanyl or methamphetamine. This suggests that many individuals consuming nitazenos may be doing so unknowingly, as these drugs often act as adulterants in other substances.
Rapid Expansion of the Illicit Market
The researchers have issued warnings about the rapid expansion of nitazenos within the illicit drug market. The difficulty in detecting these substances—given that they can appear in various formats—complicates treatment for overdoses caused by them. The team’s study has been accepted for publication in the journal Pain Medicine , although a pre-publication version is currently under review.
The Need for Research and Response
Despite being known for over half a century, nitazenos have never been properly studied, nor have they been approved for medical use. As researchers pointed out, a deeper understanding of these drugs could aid in devising appropriate responses, including the effectiveness of naloxone in counteracting overdoses caused by nitazenos. They emphasized the importance of educational efforts combined with the introduction of rapid testing methods to detect these substances more effectively.
Addressing this “ public health emergency ” necessitates a collaborative approach involving healthcare professionals , law enforcement, and community organizations. Together, these groups can implement harm reduction strategies to mitigate the impact of nitazenos and other dangerous substances.
The ongoing opioid epidemic presents a staggering challenge that is constantly evolving. As new drugs like nitazenos emerge, they exemplify the pressing need for continued research, public awareness campaigns, and comprehensive strategies to combat this crisis. Only through collaboration and understanding can we hope to stem the tide of overdoses and fatalities associated with these potent substances.